News & Highlights

in Research

Charles J Ryan, MD, Professor of Clinical Medicine and Urology, was awarded the Thomas Perkins Distinguished Professorship in Cancer Research.

US News & World Report released its national rankings of hospitals today, once again distinguishing UCSF Urology as one of the very best programs in the country...

Two newly appointed UCSF Urology Chief Residents, Drs. Lindsay Hampson and Anobel Odisho, were recognized by UCSF’s Graduate Medical Eduation (GME) office, receiving this year’s Excellence and Innovation in GME award.

As an expert in capital markets, Carl Kawaja knows a good investment when he sees one...

The first ancillary study approved by the ambitious Health eHeart Study was born here at UCSF’s Department of Urology...

Drew Armstrong of Bloomerg covered results from recent study looking at men whose prostate cancer relapsed and delayed hormone theraphy treatment.

UCSF researchers make an important scientific breakthrough that connects two fundamental cellular processes, protein synthesis and metabolism, important for fueling cancer cell growth. Remarkably, the targeted inhibition of this specific connection caused cancer cells but not normal cells to die, therefore identifying an attractive new approach to cancer therapy.

Study offers new data on hormone therapy timing strategies when prostate cancer relapse is detected by rising PSA levels alone.

Pages

Tweets

Media Contact

Elizabeth Fernandez
UCSF Department of Urology
San Francisco, CA 94143
[email protected]
415/514-1592